Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Lithuania reported an outbreak of carbapenem-resistant, and for some cases, colistin-resistant, Enterobacterales in November 2019. Between 1 February and 26 November 2019, 199 cases were detected, including cases with infection as well as carriage. The majority of cases (186 cases) occurred in one single hospital (Hospital 1). Most of the carbapenem-resistant Enterobacterales (CRE) isolates were Klebsiella pneumoniae (93%), followed by Escherichia coli. In all isolates, carbapenem resistance was mediated by a Klebsiella pneumoniae carbapenemase (KPC) enzyme.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!